Wigginton Jon Marc 4
4 · MACROGENICS INC · Filed Feb 24, 2020
Insider Transaction Report
Form 4
MACROGENICS INCMGNX
Wigginton Jon Marc
Senior VP, Clinical Dev.
Transactions
- Award
Employee stock option (right to buy)
2020-02-20$11.50/sh+100,000$1,150,000→ 100,000 totalExercise: $11.50Exp: 2030-02-20→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter.